15518
Boc-Inp-OH
≥99.0% (HPLC)
别名:
1-Boc-4-哌啶甲酸, N-Boc-异六氢烟碱酸
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C11H19NO4
化学文摘社编号:
分子量:
229.27
NACRES:
NA.22
PubChem Substance ID:
eCl@ss:
32160406
UNSPSC Code:
12352209
MDL number:
Beilstein/REAXYS Number:
5533442
产品名称
Boc-Inp-OH, ≥99.0% (HPLC)
InChI
1S/C11H19NO4/c1-11(2,3)16-10(15)12-6-4-8(5-7-12)9(13)14/h8H,4-7H2,1-3H3,(H,13,14)
SMILES string
CC(C)(C)OC(=O)N1CCC(CC1)C(O)=O
InChI key
JWOHBPPVVDQMKB-UHFFFAOYSA-N
assay
≥99.0% (HPLC)
form
solid
reaction suitability
reaction type: Boc solid-phase peptide synthesis
application(s)
peptide synthesis
Quality Level
正在寻找类似产品? 访问 产品对比指南
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
法规信息
新产品
此项目有
Xunan Jing et al.
Nanoscale, 11(33), 15508-15518 (2019-08-09)
Although the collaborative therapy of chemotherapy (CT) and photodynamic therapy (PDT) is much more efficient for tumor treatment than monotherapies, premature leakage of drugs from nanocarriers and hypoxia in the tumor microenvironment (TME) result in systemic toxicity and suboptimal therapy
Jing Zhang et al.
Cell death and differentiation, 27(5), 1569-1587 (2019-10-28)
Microtubule-targeting agents (MTAs) are a class of most widely used chemotherapeutics and their mechanism of action has long been assumed to be mitotic arrest of rapidly dividing tumor cells. In contrast to such notion, here we show-in many cancer cell
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持